Actively hiring
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
3
Y Combinator, Initialized Capital
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 2018
Went through Y Combinator
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

GeneSight Psychotropic is a pharmacogenomic test which means that it analyzes how your genes may affect medication outcomes. The GeneSight…

ゲノム ( DNA )、エピゲノム、トランスクリプトーム ( RNA )を独自の技術で解析し、研究開発の効率・精度を格段に向上させます。次世代シーケンス( NGS )/ エピジェネティクス 研究の 実験デザイン から 情報 解析、論文化、事業化までオーダーメイドで支援します。.

Conversion done right, for web and apps. Boost conversion and basket size with optimized purchase flows and payments.

Advanced single-cell solutions by Atrandi. Discover high-throughput single-cell technologies for genomics, screening, and biological…

Phase Genomics: Fueling Genomic Discovery. CytoTerra® Cytogenetics, ProxiMeta™ Metagenome Deconvolution, Proximo™ Genome Scaffolding.

In-house DNA and RNA synthesis with Kilobaser DNA & RNA Synthesizer for fastest access to molecular tools. Produce ready-to-use modified…
Overview
Cancer Genomics Done Right.. Why choose between DNA and RNA? Our test analyzes both - genomics and transcriptomics - from a single sample. Information from both available simultaneously from a single work-flow saves tissue, time, money, and effort.

Y Combinator
Initialized Capital
Leadout Capital 




